Issue link: https://beckershealthcare.uberflip.com/i/1368676
67 GASTROENTEROLOGY 9 studies that have GIs talking so far in 2021 By Carly Behm F rom studies on colorectal cancer risk factors to research on outpatient colo- noscopies, here are nine recent studies catching the eyes of gastroenterologists: 1. Freenome's novel multiomics blood test for colorectal cancer detected advanced adenomas with a 41 percent sensitivity at 90 percent specificity, according to results from its Ai-Emerge study. 2. Patients who received an outpatient colo- noscopy seldom go to the emergency room for unplanned complications, and of those who do it's oen for reasons unrelated to the procedure, according to a study published in Clinical and Experimental Gastroenterology. 3. Barrett's esophagus patients may be more vulnerable to COVID-19 infection in their upper gastrointestinal tract aer eating or drinking food contaminated with the virus, according to a study published Jan. 20 in Gastroenterology. 4. A study of Kaiser Permanente members in Southern California found that offering patients to self-order a colorectal cancer screening test online increases rates of test completion. 5. Family history of colorectal cancer, hyper- lipidemia, obesity and alcohol consumption could all be risk factors behind developing early-onset colorectal cancer, according to a Jan. 28 study published in Clinical Gastroen- terology and Hepatology. 6. Patients must confirm a positive stool- based colorectal cancer screening test with a colonoscopy, and delaying that follow-up colonoscopy has led to increased CRC rates, according to a study published in Gastroen- terology Feb. 2. 7. Providers attempted to improve colorec- tal cancer screening rates by using risk stratification, but recent research debunked the effectiveness of the strategy, according to a study published in February issue of e American Journal of Gastroenterology. 8. Low consumption of alcohol and red meat, along with high intake of dietary cal- cium and fiber, may lead to a decreased risk of colorectal cancer, according to a study published in JAMA Network Open. 9. A blood-based colorectal cancer test was found to be the most cost-effective alterna- tive colorectal cancer test for people who didn't want a colonoscopy or fecal immuno- chemical test, according to a study pub- lished in the Journal of the National Cancer Institute. n For more information: ASCent@Acumed.net go.acumed.net/ASC Choice is at the heart of the ASCent program, featuring our comprehensive portfolio of medical devices for simple to complex injuries in an outpatient setting. The ASCent ™ Program Customizable. Scalable. Flexible. Designed to provide Ambulatory Surgery Centers with clinical value while addressing financial needs JAD10-18-A | Effective: 2021/04 | © 2021 Acumed® LLC